Fortress Biotech Inc (FBIO) Stock Analysis

Fortress Biotech Inc (FBIO) is a publicly traded company in the HEALTHCARE sector. It trades at $2.65, carries a market capitalization of $85.37M, a price-to-earnings ratio of 0.80. This page summarizes the public market data, fundamentals, and frequently asked questions for FBIO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.65
• Market Cap: $85.37M
• P/E Ratio: 0.80
• EPS: $3.23
• 52-Week High: $4.53
• 52-Week Low: $1.70

Market Sentiment

Fortress Biotech Inc currently has a Bullish sentiment score of 0.64.

About Fortress Biotech Inc

Fortress Biotech Inc. is a biopharmaceutical firm based in New York that focuses on developing and marketing innovative pharmaceutical and biotechnology products. The company aims to address unmet medical needs through its diverse portfolio of drug candidates, which encompass various therapeutic areas, including oncology and neurology. Fortress leverages both its in-house capabilities and collaborative partnerships to enhance its drug development pipeline and drive growth, positioning itself ...

GNG Research Analysis

GNG Research scores Fortress Biotech Inc (FBIO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for FBIO.

Frequently Asked Questions

Does FBIO pay dividends?

Fortress Biotech Inc (FBIO) does not currently pay a regular dividend.

What is FBIO's P/E ratio?

Fortress Biotech Inc has a price-to-earnings (P/E) ratio of 0.80.

What is FBIO's market cap?

Fortress Biotech Inc (FBIO) has a market capitalization of $85.37M with a current stock price of $2.65.